a year ago
TEVA
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Bottom 14%
#4240 out of 4922 analysts
Average Return
-1.18%
Win Rate
38%21 out of 55
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-16 - 2024-10-16 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-02 - 2024-01-24 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +67.91% | $9.88 | $16.59 | 2023-11-26 - 2024-11-26 | Strong Buy |
Neurocrine Biosciences IncNBIX | +53.52% | $96.03 | $147.43 | 2023-07-12 - 2024-07-12 | Strong Buy |
Acadia Pharmaceuticals IncACAD | +50.89% | $14.66 | $22.12 | 2025-04-28 - 2025-06-27 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
a year ago
LEGN
a year ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | 9 | Strong Buy | $23.00 | +37.23% | Maintains | 5 days ago |
Alkermes PLCALKS | 4 | Strong Buy | $42.00 | +45.78% | Upgrades | 14 days ago |
Incyte CorpINCY | 1 | Hold | $61.00 | -10.78% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $152.00 | +21.19% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 5 | Hold | $41.00 | +23.64% | Maintains | 2 months ago |
Harmony Biosciences Holdings IncHRMY | 2 | Strong Buy | $48.00 | +50.09% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 4 | Strong Buy | $22.00 | -0.54% | Maintains | 2 months ago |
Coherus Biosciences IncCHRS | 5 | Hold | $1.05 | +41.32% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Strong Buy | $179.00 | +67.45% | Upgrades | 4 months ago |
Exelixis IncEXEL | 2 | Hold | $34.00 | -22.14% | Maintains | 5 months ago |
Avadel Pharmaceuticals PLCAVDL | 2 | Strong Buy | $14.00 | +52.17% | Maintains | 6 months ago |
United Therapeutics CorpUTHR | 4 | Strong Buy | $475.00 | +67.09% | Maintains | 6 months ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | +74.45% | Maintains | 7 months ago |
Biohaven LtdBHVN | 3 | Strong Buy | $54.00 | +283.25% | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | -40.09% | Maintains | a year ago |
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $105.00 | +1.59% | Maintains | a year ago |
Royalty Pharma PLCRPRX | 3 | Hold | $28.00 | N/A | Downgrades | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $81.00 | N/A | Maintains | a year ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 2 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.